Chester County News and Community Website
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has announced that Yummy Foods, based in Edison, NJ, is recalling its Yummy Swirly Ices line due to potential milk contamination. …
FDA Announces Recall of Yummy Swirly Ices Due to Potential Milk Contamination Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) announced that Baxter International Inc. (NYSE:BAX) is voluntarily recalling one lot of Heparin Sodium in 0.9% Sodium Chloride Injection due to …
Baxter Recalls Heparin Sodium Injection Over Elevated Endotoxin Levels Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has announced a recall by G.S. Gelato & Desserts, Inc. of a limited amount of Full Circle Market Coconutmilk Chocolate Almond Crunch …
FDA Issues Recall for Non-Dairy Frozen Dessert Due to Undeclared Allergen Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has received approval from the Food and Drug Administration to begin its expanded access program (EAP) for the treatment of adult patients with …
Ocugen Receives FDA Approval for Expanded Access Program for Retinitis Pigmentosa Treatment Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) recently published a groundbreaking analysis on the use of artificial intelligence and machine learning (AI/ML) in drug therapy decisions. This marks …
FDA Utilizes AI/ML for Drug Therapy Decision-Making Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has announced a recall of 640 packs of “Bikano Moong Dal 350g” by Thal Golden Spices Inc. of Hayward, California. The …
FDA Issues Recall for Bikano Moong Dal Over Salmonella Concerns Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) recently issued an urgent safety alert to warn consumers about the potential risks associated with Crecelac Infant Powdered Goat Milk Infant …
FDA Issues Safety Alert on Crecelac Infant Formula Due to Nutrient Imbalances and Bacterial Contamination Read More
HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) announced that the U.S. Food and Drug Administration (FDA) recently approved DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and …
FDA Approves DARZALEX FASPRO® for Newly Diagnosed Multiple Myeloma Patients Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) recently released a summary of adverse event reports (AERs) related to Purina pet food. Covering the period between November 22, 2023, and …
FDA Reviews Adverse Event Reports on Purina Pet Food Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has issued a Federal Register notice detailing the medical device user fees and annual establishment registration fees for Fiscal Year 2025 …
FDA Announces Medical Device User Fees for Fiscal Year 2025 Read More